Suchergebnisse - "Enomoto, Takayuki"

PubPharm (23)

1

Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc) : a randomised, open-label, phase 3 trial

enthalten in: Lancet (London, England) | 2024

von Oaknin, A. | Gladieff, L. | Martínez-García, J. | +117

2

Comparison of older and younger patients with ovarian cancer : A post hoc study (JGOG3016-A3) of the treatment strength and prognostic outcomes of conventional or dose-dense chemotherapy

enthalten in: The journal of obstetrics and gynaecology research | 2023

von Itani, Y. | Sakai, H. | Hamano, T. | +7

3

Intraperitoneal Carboplatin for Ovarian Cancer - A Phase 2/3 Trial

enthalten in: NEJM evidence | 2023

von Nagao, S. | Fujiwara, K. | Yamamoto, K. | +26

4

Endometrial carcinosarcoma

enthalten in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society | 2023

von Bogani, G. | Ray-Coquard, I. | Concin, N. | +37

5

Veliparib with frontline chemotherapy and as maintenance in Japanese women with ovarian cancer : a subanalysis of efficacy, safety, and antiemetic use in the phase 3 VELIA trial

enthalten in: International journal of clinical oncology | 2023

von Mizuno, M. | Ito, K. | Nakai, H. | +18

6

Incidence of gastrointestinal perforation associated with bevacizumab in combination with neoadjuvant chemotherapy as first-line treatment of advanced ovarian, fallopian tube, or peritoneal cancer : analysis of a Japanese healthcare claims database

enthalten in: Journal of gynecologic oncology | 2022

von Ueda, A. | Watari, H. | Mandai, M. | +5

7

Paclitaxel-carboplatin and bevacizumab combination with maintenance bevacizumab therapy for metastatic, recurrent, and persistent uterine cervical cancer : An open-label multicenter phase II trial (JGOG1079)

enthalten in: Gynecologic oncology | 2022

von Tanigawa, T. | Takeshima, N. | Ishikawa, H. | +21

8

Adjuvant Chemotherapy for Endometrial Cancer (ACE) trial : A randomized phase II study for advanced endometrial carcinoma

enthalten in: Cancer science | 2022

von Egawa-Takata, T. | Ueda, Y. | Ito, K. | +18

9

The post-progression survival of patients with recurrent or persistent ovarian clear cell carcinoma : results from a randomized phase III study in JGOG3017/GCIG

enthalten in: Journal of gynecologic oncology | 2020

von Kondo, E. | Tabata, T. | Suzuki, N. | +12

10

Randomized Phase III Trial of Irinotecan Plus Cisplatin Compared With Paclitaxel Plus Carboplatin As First-Line Chemotherapy for Ovarian Clear Cell Carcinoma : JGOG3017/GCIG Trial

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2016

von Sugiyama, T. | Okamoto, A. | Enomoto, T. | +21